ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $130 | – | 200 | -22.5% | 0.00% | – |
Q2 2022 | $0 | – | 258 | -80.8% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 1,344 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | -94.6% | 1,344 | -93.5% | 0.00% | – |
Q3 2021 | $37,000 | -42.2% | 20,674 | -15.5% | 0.00% | – |
Q2 2021 | $64,000 | +255.6% | 24,458 | +377.3% | 0.00% | – |
Q1 2021 | $18,000 | +50.0% | 5,124 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | 0.0% | 5,124 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -88.0% | 5,124 | -83.1% | 0.00% | – |
Q2 2020 | $100,000 | -10.7% | 30,284 | -33.1% | 0.00% | – |
Q1 2020 | $112,000 | -21.7% | 45,286 | +49.3% | 0.00% | – |
Q4 2019 | $143,000 | +10.0% | 30,336 | 0.0% | 0.00% | – |
Q3 2019 | $130,000 | +333.3% | 30,336 | +468.5% | 0.00% | – |
Q2 2019 | $30,000 | +42.9% | 5,336 | 0.0% | 0.00% | – |
Q1 2019 | $21,000 | +133.3% | 5,336 | 0.0% | 0.00% | – |
Q4 2018 | $9,000 | -97.5% | 5,336 | -95.2% | 0.00% | – |
Q3 2018 | $356,000 | +6.3% | 110,936 | 0.0% | 0.00% | – |
Q2 2018 | $335,000 | -23.3% | 110,936 | -0.4% | 0.00% | – |
Q1 2018 | $437,000 | -5.4% | 111,436 | 0.0% | 0.00% | – |
Q4 2017 | $462,000 | -32.6% | 111,436 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $685,000 | -1.2% | 111,436 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $693,000 | -1.8% | 111,436 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $706,000 | +18.3% | 111,436 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $597,000 | -4.9% | 111,436 | -0.0% | 0.00% | 0.0% |
Q3 2016 | $628,000 | -3.1% | 111,457 | -5.6% | 0.00% | 0.0% |
Q2 2016 | $648,000 | -25.7% | 118,038 | +0.3% | 0.00% | 0.0% |
Q1 2016 | $872,000 | -11.6% | 117,640 | -0.8% | 0.00% | 0.0% |
Q4 2015 | $986,000 | -8.4% | 118,619 | -0.8% | 0.00% | 0.0% |
Q3 2015 | $1,077,000 | -47.0% | 119,619 | -29.3% | 0.00% | -50.0% |
Q2 2015 | $2,031,000 | +30.3% | 169,210 | +16.8% | 0.00% | 0.0% |
Q1 2015 | $1,559,000 | +153.9% | 144,887 | +19.8% | 0.00% | +100.0% |
Q4 2014 | $614,000 | +100.0% | 120,930 | +4.4% | 0.00% | – |
Q3 2014 | $307,000 | -28.8% | 115,886 | +8.4% | 0.00% | -100.0% |
Q2 2014 | $431,000 | -12.2% | 106,930 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $491,000 | +6.3% | 106,930 | +0.3% | 0.00% | 0.0% |
Q4 2013 | $462,000 | +10.0% | 106,600 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $420,000 | +87.5% | 106,600 | 0.0% | 0.00% | – |
Q2 2013 | $224,000 | – | 106,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |